The CFAP57 gene helps tiny hair-like cilia move in a coordinated way, especially in the airways, where they clear mucus and trapped germs. This gene plays an important role in keeping that motion smooth and effective. If you carry pathogenic variants in both copies of the CFAP57 gene, the cilia may not work well, which can lead to primary ciliary dyskinesia, with ongoing chest congestion, sinus or ear problems, and sometimes reduced fertility.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how strongly they are carried out. Taken as a whole, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
CFAP57Gene function
What if the gene works
The CFAP57 gene helps tiny hairlike structures called cilia move in a coordinated way. This supports mucus clearance in the airways and normal movement of sperm.
Risk
What if the gene does not work
Variants in the CFAP57 gene are linked to primary ciliary dyskinesia. Many people have ongoing sinus or chest infections and a chronic wet cough; milder to more severe variants can affect how early symptoms appear and how pronounced they are.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the CFAP57 gene, no CFAP57-specific treatment or drug choice approach is currently established. Care is based on the person's symptoms and standard treatment for the related condition, while the CFAP57 gene is mainly being studied to better understand cilia problems rather than as a current drug target.
Gene function
What if the gene works
Tiny hairlike structures called motile cilia need the CFAP57 gene to move in a smooth, patterned way. Its protein becomes part of the cilia’s inner framework and helps movement proteins sit in the right places. This supports the steady sweeping action that moves fluid and mucus across certain body surfaces.
Inside motile cilia, the CFAP57 gene helps place dynein proteins (tiny motors) at specific spots along the inner scaffold. This careful layout lets the cilium generate force in an organized way.
By arranging these motors, the CFAP57 gene supports the bend and rhythm of cilia as they sweep back and forth. This is central to how the CFAP57 gene helps motile cilia move fluid across body surfaces.
The protein made from the CFAP57 gene helps different parts of a cilium pull in a coordinated sequence. That timing gives each beat a smooth, repeatable pattern rather than a random twitch.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CFAP57 gene can alter the protein’s shape or reduce how much of it a cell makes, which may disrupt how motor proteins are arranged inside cilia. In primary ciliary dyskinesia, how CFAP57 gene variants affect cilia movement often depends on severity: milder variants may leave some activity, while more severe variants can stop the protein from working almost completely. This can produce a more abnormal cilia beat and, in some cases, earlier or more noticeable symptoms.
How variants are linked to conditions
Certain pathogenic variants in the CFAP57 gene can cause a form of primary ciliary dyskinesia, an inherited condition linked to ongoing chest infections, chronic sinus and ear problems, and later bronchiectasis (widened airways in the lungs). In people with CFAP57 gene variants linked to primary ciliary dyskinesia, symptoms often begin in childhood, though the pattern can vary from person to person. Some men with this condition may also have reduced fertility.
A variant is not necessarily a diagnosis
Genetic variants are a common and expected part of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. In other situations, one well-characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For CFAP57, risk is mainly shaped by inheritance rather than lifestyle. A child is at higher risk only if both biological parents carry a harmful CFAP57 change; family history and parents being related by blood can make this more likely. There is not enough evidence to say that diet, exercise, or other everyday habits change this genetic risk.
Inheritance of CFAP57 variants
CFAP57-related conditions are inherited in an autosomal recessive pattern. That means a child usually inherits one CFAP57 variant from each parent, and the parents are often healthy carriers. When both parents carry a variant in the CFAP57 gene, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how CFAP57 is inherited is the same for sons and daughters because this gene is on a non-sex chromosome.
What does my CFAP57 result mean for my family?
For CFAP57, family implications usually fit a recessive pattern. This means parents are often healthy carriers, brothers and sisters may also be affected or may be carriers, and close relatives could want to learn whether they carry the same gene change. Children of someone with a CFAP57-related condition will usually inherit one changed copy, and risk to their own children depends on the other parent’s result.
Genetic information
Genetic testing
How you find out about variants
CFAP57 genetic testing uses a blood or saliva sample to read the gene’s DNA code and look for variants. It can help show whether you carry a CFAP57 variant linked to primary ciliary dyskinesia, or whether the result is negative or uncertain.
When should I consider getting a genetic test?
Consider genetic testing for the CFAP57 gene if you or your child has signs of an inherited cilia condition, such as a daily wet cough, repeated sinus or chest infections, or trouble getting pregnant linked to poor sperm movement. Testing may also make sense when these problems run in the family or when doctors suspect primary ciliary dyskinesia.
A genetic result is only one part of your health story
A genetic finding may provide useful information, but what it can tell you varies based on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may work differently from one person to another. Some people break down a drug faster or slower, while others may be more or less sensitive to its effects. These differences are common and can influence how well a medicine works or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences shape how people respond to medicines. It studies gene-drug relationships to clarify why the same treatment can affect one person differently from another. With many medications, genes influence both how strongly a drug works and how the body processes it. This information can support more personalized and informed treatment choices. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the CFAP57 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in how medicines work, so questions about side effects, treatment choices, or new symptoms are best discussed with your doctor.
History
CFAP57 entered the medical literature through research on the tiny moving structures called cilia and flagella, first in laboratory models and later in people with inherited breathing and fertility problems. In recent decades, awareness of this gene’s role has grown as better DNA sequencing made it easier to connect rare gene variants with specific cilia-related conditions. Building on this early work, scientists linked CFAP57 variants to some cases of primary ciliary dyskinesia, a condition that can affect mucus clearance in the airways. That discovery helped place CFAP57 within the expanding group of genes involved in inherited cilia conditions. Its history is mainly part of the broader modern effort to map rare genetic causes of long-standing family patterns of illness.